14-day Premium Trial Subscription Try For FreeTry Free
Tuesday 14, 2020 – ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a Swiss clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious condition
Renaissance Technologies LLC lifted its holdings in Obseva SA (NASDAQ:OBSV) by 154.7% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchan
In 2012 Ernest Loumaye was appointed CEO of ObsEva SA (NASDAQ:OBSV). First, this article will compare CEO compensation...

Obseva (NASDAQ:OBSV) Trading Up 7.7%

10:16am, Tuesday, 07'th Apr 2020
Obseva SA (NASDAQ:OBSV)’s share price was up 7.7% during trading on Monday . The company traded as high as $2.36 and last traded at $2.25, approximately 326,787 shares changed hands during trading.
April 6, 2020 – ObsEva SA (OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health today announced the nomination of
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA (OBSV), AC Immune SA (ACIU) and Co-Diagnostics
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on ObsEva SA
Obseva (NASDAQ:OBSV) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a research report issued on Saturday, Zacks.com reports. The brokerage presently has a

ObsEva SA: New Date Announcement for AGM

06:00am, Friday, 27'th Mar 2020
Geneva, Switzerland and Boston, MA – March 27, 2020 – ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company developing and commercializing novel therapies to.
Obseva SA (NASDAQ:OBSV) has earned an average recommendation of “Hold” from the seven research firms that are currently covering the stock, MarketBeat.com reports. Two research analysts have rated
Q4 2019 Obseva SA Earnings Call

Obseva (NASDAQ:OBSV) Shares Up 5.1%

08:34am, Thursday, 26'th Mar 2020
Obseva SA (NASDAQ:OBSV) shot up 5.1% during mid-day trading on Tuesday . The stock traded as high as $2.11 and last traded at $2.07, 276,091 shares changed hands during trading. A decline of 60% from
Obseva (NASDAQ:OBSV)‘s stock had its “buy” rating reissued by equities researchers at Wedbush in a research note issued to investors on Monday, TipRanks reports. They currently have a $34.00 pri

ObsEva SA (OBSV) Receives a Buy from Wedbush

02:10am, Tuesday, 24'th Mar 2020
Wedbush analyst Liana Moussatos reiterated a Buy rating on ObsEva SA (OBSV) yesterday and set a price target of $34.00. The company's shares closed last
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE